Having trouble accessing articles? Reset your cache.

RoActemra tocilizumab regulatory update

The U.K.'s NICE issued guidance recommending the use of Roche's RoActemra tocilizumab in combination with methotrexate to

Read the full 174 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE